BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: White RE, Parker RK, Fitzwater JW, Kasepoi Z, Topazian M. Stents as sole therapy for oesophageal cancer: A prospective analysis of outcomes after placement. Lancet Oncol. 2009;10:240-246. [PMID: 19230771 DOI: 10.1016/s1470-2045(09)70004-x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Mwachiro MM, Parker RK, Chepkwony R, Burgert SL, White RE. Esophageal stent placement without optical or fluoroscopic visualization. VideoGIE 2017;2:309-11. [PMID: 30027132 DOI: 10.1016/j.vgie.2017.07.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Vermeulen BD, Siersema PD. Esophageal Stenting in Clinical Practice: an Overview. Curr Treat Options Gastroenterol. 2018;16:260-273. [PMID: 29557070 DOI: 10.1007/s11938-018-0181-3] [Cited by in Crossref: 32] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
3 Aoki Y, Hihara J, Sakogawa K, Taomoto J, Hamai Y, Emi M, Okada M. Advanced esophageal cancer with an esophago-bronchial fistula successfully treated by chemoradiotherapy following esophageal bypass surgery: report of a case. Surg Today 2012;42:1088-90. [PMID: 22955635 DOI: 10.1007/s00595-012-0323-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
4 Kanyi JK, Ogada TV, Oloo MJ, Parker RK. Burr-Hole Craniostomy for Chronic Subdural Hematomas by General Surgeons in Rural Kenya. World J Surg 2018;42:40-5. [PMID: 28741193 DOI: 10.1007/s00268-017-4143-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
5 Blanchard C, Lubuzo B, Asirwa FC, Dlamini X, Msadabwe-Chikuni SC, Mwachiro M, Shyirambere C, Ruhangaza D, Milner DA Jr, Van Loon K, DeBoer R, Mtshali P, Dugan U, Baker E, Shulman LN. Multisector Collaborations and Global Oncology: The Only Way Forward. JCO Glob Oncol 2021;7:153-61. [PMID: 33493021 DOI: 10.1200/GO.20.00492] [Reference Citation Analysis]
6 Sigounas DE, Krystallis C, Couper G, Paterson-Brown S, Tatsioni A, Plevris JN. Argon plasma coagulation compared with stent placement in the palliative treatment of inoperable oesophageal cancer. United European Gastroenterol J 2017;5:21-31. [PMID: 28405318 DOI: 10.1177/2050640616650786] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
7 Loots E, Sartorius B, Madiba TE, Mulder CJ, Clarke DL. Is Clinical Research in Oesophageal Cancer in South Africa in Crisis? A Systematic Review. World J Surg 2017;41:810-6. [PMID: 27807706 DOI: 10.1007/s00268-016-3778-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
8 Wen L, Quan H, Li L, Huang C, Chen X, Yang Y, Wang L, He X, Zhang X. The clinical research of the endoscopic sequential treatment for patients with intermediate-advanced esophageal cancer: a randomized clinical trial. Med Oncol 2014;31:284. [PMID: 25380842 DOI: 10.1007/s12032-014-0284-1] [Reference Citation Analysis]
9 Zhang F, Ji G, Fan Z. Stents can be the first choice. The Lancet Oncology 2009;10:541-2. [DOI: 10.1016/s1470-2045(09)70138-x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
10 Mmbaga EJ, Deardorff KV, Mushi B, Mgisha W, Merritt M, Hiatt RA, Mwaiselage J, Zhang L, Van Loon K. Characteristics of Esophageal Cancer Cases in Tanzania. J Glob Oncol. 2018;4:1-10. [PMID: 30241222 DOI: 10.1200/jgo.2016.006619] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
11 Mushi BP, Mwachiro MM, Buckle G, Kaimila BN, Mulima G, Kayamba V, Kelly P, Akoko L, Mmbaga EJ, Selekwa M, Ringo Y, Pritchett N, White RE, Topazian MD, Fleischer DE, Dawsey SM, Van Loon K. Improving Access to Self-Expanding Metal Stents for Patients With Esophageal Cancer in Eastern Africa: A Stepwise Implementation Strategy. JCO Glob Oncol 2021;7:118-26. [PMID: 33449802 DOI: 10.1200/GO.20.00318] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Buckle GC, Mrema A, Mwachiro M, Ringo Y, Selekwa M, Mulima G, Some FF, Mmbaga BT, Mody GN, Zhang L, Paciorek A, Akoko L, Ayuo P, Burgert S, Bukusi E, Charles A, Chepkemoi W, Chesumbai G, Kaimila B, Kenseko A, Kibwana KS, Koech D, Macharia C, Moirana EN, Mushi BP, Mremi A, Mwaiselage J, Mwanga A, Ndumbalo J, Nvakunga G, Ngoma M, Oduor M, Oloo M, Opakas J, Parker R, Seno S, Salima A, Servent F, Wandera A, Westmoreland KD, White RE, Williams B, Mmbaga EJ, Van Loon K; of the African Esophageal Cancer Consortium (AfrECC). Treatment outcomes of esophageal cancer in Eastern Africa: protocol of a multi-center, prospective, observational, open cohort study. BMC Cancer 2022;22:82. [PMID: 35045815 DOI: 10.1186/s12885-021-09124-5] [Reference Citation Analysis]
13 Parker RK, Dawsey SM, Abnet CC, White RE. Frequent occurrence of esophageal cancer in young people in western Kenya. Dis Esophagus. 2010;23:128-135. [PMID: 19473205 DOI: 10.1111/j.1442-2050.2009.00977.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 3.2] [Reference Citation Analysis]
14 Janmaat VT, Steyerberg EW, van der Gaast A, Mathijssen RH, Bruno MJ, Peppelenbosch MP, Kuipers EJ, Spaander MC. Palliative chemotherapy and targeted therapies for esophageal and gastroesophageal junction cancer. Cochrane Database Syst Rev. 2017;11:CD004063. [PMID: 29182797 DOI: 10.1002/14651858.cd004063.pub4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
15 Mwachiro MM, Parker RK, Pritchett NR, Lando JO, Ranketi S, Murphy G, Chepkwony R, Burgert SL, Abnet CC, Topazian MD, Dawsey SM, White RE. Investigating tea temperature and content as risk factors for esophageal cancer in an endemic region of Western Kenya: Validation of a questionnaire and analysis of polycyclic aromatic hydrocarbon content. Cancer Epidemiol 2019;60:60-6. [PMID: 30925281 DOI: 10.1016/j.canep.2019.03.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
16 Murphy G, McCormack V, Abedi-Ardekani B, Arnold M, Camargo MC, Dar NA, Dawsey SM, Etemadi A, Fitzgerald RC, Fleischer DE, Freedman ND, Goldstein AM, Gopal S, Hashemian M, Hu N, Hyland PL, Kaimila B, Kamangar F, Malekzadeh R, Mathew CG, Menya D, Mulima G, Mwachiro MM, Mwasamwaja A, Pritchett N, Qiao YL, Ribeiro-Pinto LF, Ricciardone M, Schüz J, Sitas F, Taylor PR, Van Loon K, Wang SM, Wei WQ, Wild CP, Wu C, Abnet CC, Chanock SJ, Brennan P. International cancer seminars: a focus on esophageal squamous cell carcinoma. Ann Oncol 2017;28:2086-93. [PMID: 28911061 DOI: 10.1093/annonc/mdx279] [Cited by in Crossref: 66] [Cited by in F6Publishing: 66] [Article Influence: 16.5] [Reference Citation Analysis]
17 Asombang AW, Chishinga N, Nkhoma A, Chipaila J, Nsokolo B, Manda-Mapalo M, Montiero JFG, Banda L, Dua KS. Systematic review and meta-analysis of esophageal cancer in Africa: Epidemiology, risk factors, management and outcomes. World J Gastroenterol 2019; 25(31): 4512-4533 [PMID: 31496629 DOI: 10.3748/wjg.v25.i31.4512] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
18 Hamer PW, Griffiths EA, Devitt PG. Tracheo-oesophageal fistula after palliative treatment of oesophageal cancer. J Gastrointest Oncol 2015;6:E86-8. [PMID: 26487957 DOI: 10.3978/j.issn.2078-6891.2015.063] [Reference Citation Analysis]
19 Liu W, Snell JM, Jeck WR, Hoadley KA, Wilkerson MD, Parker JS, Patel N, Mlombe YB, Mulima G, Liomba NG, Wolf LL, Shores CG, Gopal S, Sharpless NE. Subtyping sub-Saharan esophageal squamous cell carcinoma by comprehensive molecular analysis. JCI Insight 2016;1:e88755. [PMID: 27734031 DOI: 10.1172/jci.insight.88755] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.7] [Reference Citation Analysis]
20 Fujita T, Tanabe M, Shimizu K, Iida E, Matsunaga N. Radiological image-guided placement of covered Niti-S stent for palliation of dysphagia in patients with cervical esophageal cancer. Dysphagia. 2013;28:253-259. [PMID: 23370813 DOI: 10.1007/s00455-013-9446-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
21 Dai Z, Zhou D, Hu J, Zhang L, Lin Y, Zhang J, Li F, Liu P, Li H, Cao F. Clinical application of iodine-eluting stent in patients with advanced esophageal cancer. Oncol Lett 2013;6:713-8. [PMID: 24137396 DOI: 10.3892/ol.2013.1466] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
22 Van Loon K, Mwachiro MM, Abnet CC, Akoko L, Assefa M, Burgert SL, Chasimpha S, Dzamalala C, Fleischer DE, Gopal S, Iyer PG, Kaimila B, Kayamba V, Kelly P, Leon ME, Mathew CG, Menya D, Middleton D, Mlombe Y, Mmbaga BT, Mmbaga E, Mulima G, Murphy G, Mushi B, Mwanga A, Mwasamwaja A, Parker MI, Pritchett N, Schüz J, Topazian MD, White RE, McCormack V, Dawsey SM. The African Esophageal Cancer Consortium: A Call to Action. J Glob Oncol 2018;4:1-9. [PMID: 30241229 DOI: 10.1200/JGO.17.00163] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
23 Duron V, Bii J, Mutai R, Ngetich J, Harrington D, Parker R, White R. Esophageal cancer awareness in Bomet district, Kenya. Afr Health Sci 2013;13:122-8. [PMID: 23658578 DOI: 10.4314/ahs.v13i1.17] [Cited by in F6Publishing: 3] [Reference Citation Analysis]